Cargando…

Effectiveness of Combined Anti-programmed Death-ligand 1 Therapy and Radiotherapy for Metastatic Merkel Cell Carcinoma: Two Case Reports

Detalles Bibliográficos
Autores principales:	TSUNODA, Kanako, ONISHI, Masazumi, MIURA, Shinpei, AMANO, Hiroo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207656/ https://www.ncbi.nlm.nih.gov/pubmed/32720697 http://dx.doi.org/10.2340/00015555-3593

Ejemplares similares

A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata effectively treated with a tumor necrosis factor α inhibitor
por: Miura, Shinpei, et al.
Publicado: (2023)

Angiosarcoma of the Auricle in a Patient with Xeroderma Pigmentosum Variant
por: Onishi, Masazumi, et al.
Publicado: (2020)

Radiotherapy for Metastatic Merkel Cell Carcinoma: A Review of the Literature
por: Khan, Luluel, et al.
Publicado: (2012)

Lower limb ulcers due to an absent inferior vena cava
por: Miura, Shinpei, et al.
Publicado: (2022)

Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
por: Walker, John W, et al.
Publicado: (2020)

Psoriatic arthritis flare-up after a second dose of BNT162b2 COVID-19 mRNA vaccine
por: Watabe, Daisuke, et al.
Publicado: (2022)

Merkel cell polyomavirus in Merkel cell carcinoma of Italian patients
por: Paolini, Francesca, et al.
Publicado: (2011)

The role of radiotherapy in the updated German S2k guideline for management of Merkel cell carcinoma
por: Vordermark, Dirk, et al.
Publicado: (2023)

Expression of Programmed Death-Ligand 1 and Programmed Death-1 in Patients with Extramammary Paget's Disease
por: Goto, Hiroyuki, et al.
Publicado: (2021)

Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma
por: Hanna, Glenn J., et al.
Publicado: (2020)

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
por: Kaufman, Howard L., et al.
Publicado: (2018)

Improving the synergistic combination of programmed death‐1/programmed death ligand‐1 blockade and radiotherapy by targeting the hypoxic tumour microenvironment
por: Mudassar, Faiqa, et al.
Publicado: (2022)

Glucose-6-phosphate dehydrogenase correlates with tumor immune activity and programmed death ligand-1 expression in Merkel cell carcinoma
por: Nakamura, Motoki, et al.
Publicado: (2020)

Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab
por: Bloom, Brooke C., et al.
Publicado: (2019)

Response to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and Pancreas
por: Mantripragada, Kalyan, et al.
Publicado: (2015)

Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis
por: Maiorano, Brigida Anna, et al.
Publicado: (2023)

Complete response to an anti-programmed cell death 1 antibody following a combination therapy of an anti-programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinoma
por: Kurokawa, Masayuki, et al.
Publicado: (2023)

Crohn's disease is facilitated by a disturbance of programmed death‐1 ligand 2 on blood dendritic cells
por: Faleiro, Rebecca, et al.
Publicado: (2019)

Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series
por: LoPiccolo, Jaclyn, et al.
Publicado: (2019)

Metastatic Merkel cell carcinoma response to nivolumab
por: Walocko, Frances M., et al.
Publicado: (2016)

Risk of second cancers after the diagnosis of Merkel cell carcinoma in Scandinavia
por: Bzhalava, D, et al.
Publicado: (2011)

No Association between Merkel Cell Polymavirus Infection and Keratoacanthoma in Korean Patients
por: Kim, Dae-Kwang
Publicado: (2019)

Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma
por: Nie, Run-Cong, et al.
Publicado: (2020)

Clinical Response to Anti–Programmed Death 1 After Response and Subsequent Progression on Anti–Programmed Death Ligand 1 Therapy
por: Castellanos, Emily H., et al.
Publicado: (2017)

Expression of Programmed Death-Ligand 1 in Cutaneous Squamous Cell Carcinoma Arising in Sun-Exposed and Nonsun-Exposed Skin
por: Goto, Hiroyuki, et al.
Publicado: (2020)

Merkel cell carcinoma metastatic to the small bowel mesentery
por: Matkowskyj, Kristina A., et al.
Publicado: (2011)

Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
por: Bullement, Ash, et al.
Publicado: (2019)

Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
por: Walocko, Frances M., et al.
Publicado: (2017)

Challenges of New Approaches in Metastatic Merkel Cell Carcinoma
por: Monteiro, Ana, et al.
Publicado: (2020)

An Extremely Rare Case of Metastatic Merkel Carcinoma of the Liver
por: Thomas, Mathew, et al.
Publicado: (2021)

Avelumab-induced Pneumonitis in Metastatic Merkel Cell Carcinoma
por: Morimoto, Toshiki, et al.
Publicado: (2022)

Merkel Cell Carcinoma: Mind the Genital Metastatic Sites!
por: Santandrea, Giacomo, et al.
Publicado: (2023)

A Review of Radiotherapy for Merkel Cell Carcinoma of the Head and Neck
por: Lee, Justin, et al.
Publicado: (2012)

Merkel Cell Carcinoma: When Does Size Matter for Radiotherapy?
por: Kasraei, Farshad, et al.
Publicado: (2015)

Update on the psychometric properties and minimal important difference (MID) thresholds of the FACT-M questionnaire for use in treatment-naïve and previously treated patients with metastatic Merkel cell carcinoma
por: Bharmal, Murtuza, et al.
Publicado: (2020)

Combined treatment with radiotherapy, chemotherapy and avelumab results in regression of metastatic Merkel cell carcinoma and improvement of associated Lambert-Eaton myasthenic syndrome: A case report
por: Green, Caroline, et al.
Publicado: (2022)

Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program
por: Grignani, Giovanni, et al.
Publicado: (2021)

Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression
por: Zheng, Nan-Nan, et al.
Publicado: (2020)

Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
por: Iafolla, Marco A. J., et al.
Publicado: (2017)

Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
por: Yu, Wei-Bo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ejsc6uil2iftrsscfd59v48jei